A Pathophysiologic, Gastroenterologic, and Radiologic Approach to the Management of Gastric Varices

Gastroenterology

Volumn 126, Issue 4, 2004, Pages 1175-1189

  Ryan, Barbara M ^a   Stockbrugger, Reinhold W ^b   Ryan, J Mark ^c  

^a MANCHESTER ROYAL INFIRMARY   (United Kingdom)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BUCRILATE; CIPROFLOXACIN; CYANOACRYLATE DERIVATIVE; ENBUCRILATE; MONOETHANOLAMINE OLEATE; NITRATE; OCTREOTIDE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SCLEROSING AGENT; SOMATOSTATIN; SOMATOSTATIN DERIVATIVE; THROMBIN; VASOPRESSIN; VASOPRESSIN DERIVATIVE;

ANATOMY; ANTIBIOTIC PROPHYLAXIS; BALLOON DILATATION; BALLOON OCCLUDED ENDOSCOPIC INJECTION SCLEROTHERAPY; BALLOON OCCLUDED RETROGRADE TRANSVENOUS OBLITERATION; BALLOON TAMPONADE; BLEEDING; BRAIN EMBOLISM; CHEMOPROPHYLAXIS; CLINICAL FEATURE; CLINICAL TRIAL; DISEASE CLASSIFICATION; DISEASE COURSE; DRUG EFFECT; DRUG EFFICACY; EMBOLISM; ENDOSCOPIC SCLEROTHERAPY; ENDOSCOPIC THERAPY; ENDOSCOPIC VEIN LIGATION; ESOPHAGUS VARICES; HEMODYNAMICS; HEPATOPULMONARY SYNDROME; HUMAN; INFECTION; INTERVENTIONAL RADIOLOGY; LUNG EMBOLISM; MORTALITY; PORTAL HYPERTENSION; PORTAL VEIN; PORTAL VEIN EMBOLISM; PORTAL VEIN THROMBOSIS; PORTOSYSTEMIC ANASTOMOSIS; PORTOSYSTEMIC PRESSURE GRADIENT; PRESSURE GRADIENT; PREVALENCE; PRIORITY JOURNAL; RECURRENT DISEASE; RETROPERITONEAL ABSCESS; REVIEW; SPLEEN INFARCTION; SPLEEN VEIN THROMBOSIS; SPLENIC VEIN; STENT; STOMACH FUNDUS; STOMACH VARICES; STOMACH VARICES BLEEDING; THROMBOSIS; VEIN LIGATION;

EID: 1842426603     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2004.01.058     Document Type: Article

References (161)

1. Sarin SK, Lahoti D, Saxena SP, Murthy NS, Makwana UK. Prevalence, classification and natural history of gastric varices: a long-term follow-up study in 568 portal hypertension patients. Hepatology 1992;16:1343-1349.
2. Smith JL, Graham DY. Variceal hemorrhage. A critical evaluation of survival analysis. Gastroenterology 1982;82:962-973.
3. D'Amico G, de Franchis R. End-of-the-century reappraisal of the 6-week outcome of upper gastrointestinal bleeding in cirrhosis. A prospective study (abstr). Gastroenterology 1999;117: A1199.
4. Rockey DC. Management of gastric varices. Gastroenterology 2001;120:1875-1877.
5. Trudeau W, Prindiville T. Endoscopic injection sclerosis in bleeding gastric varices. Gastrointest Endosc 1986;32:264-268.
6. Thakeb F, Salem SA, Abdallah M, el Batanouny M. Endoscopic diagnosis of gastric varices. Endoscopy 1994;26:287-291.
7. Bretagne JF, Dudicourt JC, Morisot D, Thevenet F, Raoul JL, Gastard J. Is endoscopic variceal sclerotherapy effective for the treatment of gastric varices. (abstr) Dig Dis Sci 1986;31:505S.
8. Sarin SK. Long-term follow-up of gastric variceal sclerotherapy: an eleven-year experience. Gastrointest Endosc 1997;46:8-14.
9. Stadelmann E. Ueber seltene formenvon blutungen im tractus gastrointestinalis. Berl Klin Wochenscher 1913;60:825-829.
10. Evans JA, Delany F. Gastric varices. Radiology 1953;60:46-50.
11. Feldman M, Feldman M. Gastric varices. Gastroenterology 1956;30:318-321.
12. Karr S, Wohl GT. Clinical importance of gastric varices. N Engl J Med 1960;263:665-669.
13. Sarin SK, Kumar A. Gastric varices: profile, classification, and management. Am J Gastroenterol 1989;84:1244-1249.
14. Sarin SK, Primignani M, Agarwal SR. Gastric varices. In: de Franchis R, ed. Portal hypertension. Proceedings of the third Baveno international consensus workshop on definitions, methodology and therapeutic strategies. Blackwell Science, London: 2001:76-96.
15. Hosking SW, Johnson AG. Gastric varices: a proposed classification leading to management. Br J Surg 1988;75:195-196.
16. Hashizume M, Kitano S, Yamaga H, Koyanagi N, Sugimachi K. Endoscopic classification of gastric varices. Gastrointest Endosc 1990;36:276-280.
17. Yasumoto M. Clinical observations on 100 cases of gastric varices. Jpn J Gastroenterol 1971;68:721-739.
18. Idezuki Y, Hypertension JRSP. General rules for recording endoscopic findings of esophago-gastric varices. World J Surg 1991;19:420-423.
19. Rosch W. Isolated gastric varices: a hint to pancreatic disorders. Endoscopy 1974;6:217-220.
20. Madsen MS, Petersen TH, Sommer H. Segmental portal hypertension. Ann Surg 1986;204:72-77.
21. Sutton JP, Yarborough DY, Richards JT. Isolated splenic vein occlusion. Arch Surg 1970;100:623-626.
22. Evan GR, Yellin AE, Weaver FA, Stain SC. Sinistral (left-sided) portal hypertension. Am Surg 1990;56:758-763.
23. Spence RAJ. The venous anatomy of the lower oesophagus in normal subjects and in patients with varices: an image analysis study. Br J Surg 1984;71:739-744.
24. Mohletaler C, Gerlock AJ, Goncharenko V, Avant GR, Flexner JM. Gastric varices secondary to splenic vein occlusion: radiographic diagnosis and clinical significance. Radiology 1979;132:593-598.
25. Okuda K, Yasumoto M, Goto A, Kunisaki T. Endoscopic observations of gastric varices. Am J Gastroenterol 1973;60:357-365.
26. Lo GH, Lai KH, Cheng JS, Huang RL, Wang SJ, Chiang HT. Prevalence of paraesophageal varices and gastric varices in patients achieving variceal obliteration by banding ligation and by injection sclerotherapy. Gastrointest Endosc 1999;49:428-436.
27. Okuda K, Suzuki K, Musha H, Arimizu N. Percutaneous transhepatic catheterization of the portal vein for the study of portal hemodynamics and shunts: a preliminary report. Gastroenterology 1977;73:279-284.
28. Lunderquist A, Vang J. Transhepatic catheterization and obliteration of the coronary vein in patients with portal hypertension and esophageal varices. N Engl J Med 1974;291:646-649.
29. Vianna A, Hayes PC, Moscoso G, Driver MO, Portmann B, Westaby D, Williams R. Normal venous circulation of the gastroesophageal junction: a route to understanding varices. Gastroenterology 1987;93:876-889.
30. Anderson CA. GI magnetic resonance angiography. Gastrointest Endosc 2002;55:S42-S48.
31. Watanabe K, Kimura K, Matsutani S, Ohto M, Okuda K. Portal hemodynamics in patients with gastric varices. A study in 230 patients with esophageal and/ or gastric varices using portal vein catheterization. Gastroenterology 1988;95:434-440.
32. Hashizume M, Kitano S, Sugimachi K, Sueishi K. Three-dimensional view of the vascular structure of the lower oesophagus in clinical portal hypertension. Hepatology 1988;8:1482-1487.
33. Arakawa M, Masuzaki T, Okuda K. Pathomorphology of esophageal and gastric varices. Semin Liver Dis 2002;22:73-82.
34. Matsumoto A, Hamamoto N, Nomura T, Hongou Y, Arisaka Y, Morikawa H, Hirata I, Katsu K. Balloon-occluded retrograde transvenous obliteration of high-risk gastric fundal varices. Am J Gastroenterol 1999;94:643-649.
35. Sarin SK, Lahoti D. Management of gastric varices. Baillieres Clin Gastroenterol 1992;6:527-548.
36. Little AG, Moosa AR. Gastrointestinal hemorrhage from left sided portal hypertension: an unappraised complication of pancreatitis. Am J Surg 1981;141:153-158.
37. Suhocki PV, Berend KR, Trotter JF. Idiopathic splenic vein stenosis: a cause of gastric variceal hemorrhage. South Med J 2000;93:812-814.
38. Sato T, Yamazaki K, Toyota J, Karino Y, Ohmura T, Suga T. Gastric varices with splenic vein occlusion treated by splenic arterial embolization. J Gastroenterol 2000;35:290-295.
39. Garcia-Tsao G, Groszmann RJ, Fischer G, Conn HO, Atterbury CE, Glickman M. Portal pressure, presence of gastroesophageal varices and variceal bleeding. Hepatology 1985;5:419-424.
40. Adamsons RJ, Butt K, Dennis CR, Kinkhabwala M, Moskowitz H, Gordon D, Babich A. Prognostic significance of portal pressure in patients with bleeding esophageal varices. Surg Gynecol Obstet 1977;145:353-356.
41. Lebrec D, De Fleury P, Rueff B, Nahum H, Benhamou JP. Portal hypertension, size of esophageal varices, and risk of gastrointestinal bleeding in alcoholic cirrhosis. Gastroenterology 1980;79:1139-1144.
42. McLeod MK, Eckhauser FE, Turcotte JG. Significance of corrected sinusoidal pressure (CSP) in patients with cirrhosis and portal hypertension. Ann Surg 1981;194:562-567.
43. Tripathi D, Therapondos G, Jackson E, Redhead DN, Hayes PC. The role of the transjugular intrahepatic portosystemic stent shunt (TIPSS) in the management of bleeding gastric varices: clinical and haemodynamic correlations. Gut 2002;51:270-274.
44. Feu F, JC Garcia-Pagan, Bosch J, Luca A, Teres J, Escorssell A, Rodes J. Relation between portal pressure response to pharmacotherapy and risk of recurrent variceal haemorrhage in patients with cirrhosis. Lancet 1995;346:1046-1047.
45. Groszmann RJ, Bosch J, Grace ND, Conn HO, Garcia-Tsao G, Navasa M, Alberts J, Rodes J, Fischer R, Bermann M, Rofe S, Patrick M, Lerner E. Hemodynamic events in a prospective randomized trial of propranalol versus placebo in the prevention of a first variceal hemorrhage. Gastroenterology 1990;99:1401-1407.
46. D'Amico G, Pagliaro L, Bosch J. The treatment of portal hypertension: a meta-analytic review. Hepatology 1995;22:332-354.
47. Ohnishi K, Nakayama T, Koen H, Saito M, Chin N, Terabayashi H, Iida S, Nomura F, Okuda K, Hatano H. Interrelationship between type of spontaneous portal systemic shunt and portal vein pressure in patients with liver disease. Am J Gastroenterol 1985;80:561-564.
48. Sanyal AJ, Freedman AM, Luketic VA, Purdum PP 3rd, Shiffman ML, DeMeo J, Cole PE, Tisnado J. The natural history of portal hypertension after transjugular intrahepatic portosystemic shunts. Gastroenterology 1997;112:889-898.
49. Polio J, Groszmann RJ. Hemodynamic factors involved in the development and rupture of esophageal varices: a pathophysiologic approach to treatment. Semin Liver Dis 1986;6:318-331.
50. McCormick PA, Jenkins SA, McIntyre N, Burroughs AK. Why portal hypertensive varices bleed and bleed: a hypothesis. Gut 1995;36:100-103.
51. Mahal TC, Groszmann RJ. Pathophysiology of portal hypertension and variceal bleeding. Surg Clin North Am 1990;70:251-266.
52. Arakawa M, Masuzaki T, Okuda K. Pathology of fundic varices of the stomach and rupture. J Gastroenterol Hepatol 2002;17:1064-1069.
53. Kim T, Shijo H, Kokawa H, Tokumitsu H, Kubara K, Ota K, Akiyoshi N, Iida T, Yokoyama M, Okumura M. Risk factors for hemorrhage from gastric fundal varices. Hepatology 1997;25:307-312.
54. Bosch J, Garcia-Pagan JC. Complications of cirrhosis. I. Portal hypertension. J Hepatol 2000;32:141-156.
55. Korula J, Chin K, Ko Y, Yamada S. Demonstration of two distinct subsets of gastric varices. Observations during a seven-year study of endoscopic sclerotherapy. Dig Dis Sci 1991;36:303-309.
56. The North Italian Endoscopic Club for the Study and Treatment of Esophageal Varices. Prediction of the first variceal hemorrhage in patients with cirrhosis of the liver and esophageal varices. A prospective multicenter study. N Engl J Med 1988;319:983-989.
57. Palmer ED, Brick IB. Correlation between severity of esophageal varices in portal cirrhosis and their propensity toward hemmorrhage. Gastroenterology 1956;30:85-90.
58. Beppu K, Inokuchi K, Koyanagi N, Nakayama S, Sakata H, Kitano S, Kobayashi M. Prediction of variceal hemorrhage by esophageal endoscopy. Gastrointest Endosc 1981;27:213-218.
59. Jalan R, Hayes PC. UK guidelines on the management of variceal haemorrhage in cirrhotic patients. British Society of Gastroenterology. Gut 2000;46(Suppl 3-4):1111-11115.
60. Merkel C, Zoli M, Siringo S, van Buuren H, Magalotti D, Angeli P, Sacerdoti D, Bolondi L, Gatta A. Prognostic indicators of risk for first variceal bleeding in cirrhosis: a multicenter study in 711 patients to validate and improve the North Italian Endoscopic Club (NIEC) index. Am J Gastroenterol 2000;95:2915-2920.
61. Zoli M, Merkel C, Magalotti D, Gueli C, Grimaldi M, Gatta A, Bernardi M. Natural history of cirrhotic patients with small esophageal varices: a prospective study. Am J Gastroenterol 2000;95:503-508.
62. De BK, Ghoshal UC, Das AS, Nandi S, Mazumder DN. Portal hypertensive gastropathy and gastric varices before esophageal variceal sclerotherapy and after obliteration. Indian J Gastroenterol 1998;17:10-12.
63. Sarin SK, Jain AK, Lamba GS, Gupta R, Chowdhary A. Isolated gastric varices: prevalence, clinical relevance and natural history. Dig Surg 2003;20:42-47.
64. Takase Y, Ozaki A, Orii K, Nagoshi K, Okamura T, Iwasaki Y. Injection sclerotherapy of esophageal varices for patients undergoing emergency and elective surgery. Surgery 1982;92:474-479.
65. Jorge AD, Adam J, Seittert L, Segal E. Sclerotherapy of oesophageal varices-an Argentinian experience. Endoscopy 1983;15 (Suppl 1):141-143.
66. Hedberg SE, Fowler DL, Ryan RLR. Injection sclerotherapy of oesophageal varices using ethanolamine oleate. Am J Surg 1982;143:426-431.
67. Graham DY, Smith JL. The course of patients after variceal haemorrhage. Gastroenterology 1981;80:800-809.
68. Kitano S, Terblanche J, Khan D, Bornman PC. Venous anatomy of the lower oesophagus in portal hypertension: practical implications. Br J Surg 1986;73:525-531.
69. Grobe JI, Kozarek RA, Sanowski RA, LeGrand J, Kovac A. Venography during endoscopic injection sclerotherapy of oesophageal varices. Gastrointest Endosc 1984;30:6-8.
70. Grace ND, Groszmann RJ, Garcia-Tsao G, Burroughs AK, Pagliaro L, Makuch RW, Bosch J, Stiegmann GV, Henderson JM, de Franchis R, Wagner JL, Conn HO, Rodes J. Portal hypertension and variceal bleeding: an AASLD single topic symposium. Hepatology 1998;28:868-880.
71. de Franchis R. Updating consensus in portal hypertension: report of the Baveno III Consensus Workshop on definitions, methodology and therapeutic strategies in portal hypertension. J Hepatol 2000;33:846-852.
72. Hayes PC, Davis JM, Lewis JA, Bouchier IA. Meta-analysis of value of propranalol in variceal haemorrhage. Lancet 1990;336:153-156.
73. Conn HO, Grace ND, Bosch J, Groszmann RJ, Rodes J, Wright SC, Matloff DS, Garcia-Tsao G, Fisher RL, Navasa M, Drewniak SJ, Atterbury CE, Bordas JM, Lerner E, Bramante C. Members of the Boston-New Haven-Barcelona Portal Hypertension Study Group. Propranalol in the prevention of the first hemorrhage from esophagogastric varices: a multicenter, randomized clinical trial. The Boston-New Haven-Barcelona Portal Hypertension Study Group. Hepatology 1991;13:902-912.
74. Poynard T, Cales P, Pasta L, Ideo G, Pascal JP, Pagliaro L, Lebrec D. Beta-adrenergic-antagonist drugs in the prevention of gastrointestinal bleeding in patients with cirrhosis and esophageal varices. An analysis of data and prognostic factors in 589 patients from four randomized clinical trials. Franco-Italian Multicenter Study Group. N Engl J Med 1991;324:1532-1538.
75. Pascal JP, Cales P. Propranalol in the prevention of first upper gastrointestinal tract hemorrhage in patients with cirrhosis of the liver and esophageal varices. N Engl J Med 1987;317:856-861.
76. Ideo G, Bellati G, Fesce E, Grimoldi D. Nadalol can prevent the first gastrointestinal bleeding in cirrhotics: a prospective, randomized study. Hepatology 1988;8:6-9.
77. Matsumoto A, Matsumoto H, Hamamoto N, Kayazawa M. Management of gastric fundal varices associated with a gastrorenal shunt. Gut 2001;48:440-441.
78. Matsumoto A, Matsumoto H, Inokuchi H. Isolated gastric fundal varices: a challenging issue. Am J Gastroenterol 2002;97:2930-2931.
79. Jalan R, Hayes PC. Management of gastric fundal varices associated with a gastrorenal shunt. (reply) Gut 2001;48:440-441.
80. Zhou Y, Qiao L, Wu J, Hu H, Xu C. Comparison of the efficacy of octreotide, vasopressin, and omeprazole in the control of acute bleeding in patients with portal hypertensive gastropathy: a controlled study. J Gastroenterol Hepatol 2002;17:973-979.
81. Wu CY, Yeh HZ, Chen GH. Pharmacologic efficacy in gastric variceal rebleeding and survival: including multivariate analysis. J Clin Gastroenterol 2002;35:127-132.
82. Bleichner G, Boulanger R, Squara P, Sollet JP, Parent A. Frequency of infections in cirrhotic patients presenting with acute gastrointestinal haemorrhage. Br J Surg 1986;73:724-726.
83. Goulis J, Armonis A, Patch D, Sabin C, Greenslade L, Burroughs AK. Bacterial infection is independently associated with failure to control bleeding in cirrhotic patients with gastrointestinal hemorrhage. Hepatology 1998;27:1207-1212.
84. Bernard B, Cadranel JF, Valla D, Escolano S, Jarlier V, Opolon P. Prognostic significance of bacterial infection in bleeding cirrhotic patients: a prospective study. Gastroenterology 1995;108:1828-1834.
85. Bernard B, Grange JD, Khac EN, Amiot X, Opolon P, Poynard T. Antibiotic prophylaxis for the prevention of bacterial infections in cirrhotic patients with gastrointestinal bleeding: a meta-analysis. Hepatology 1999;29:1655-1661.
86. Hsieh WJ, Lin HC, Hwang SJ, Hou MC, Lee FY, Chang FY, Lee SD. The effect of ciprofloxacin in the prevention of bacterial infection in patients with cirrhosis after upper gastrointestinal bleeding. Am J Gastroenterol 1998;93:962-966.
87. Panes J, Teres J, Bosch J, Rodes J. Efficacy of balloon tamponade in treatment of bleeding gastric and esophageal varices. Results in 151 consecutive episodes. Dig Dis Sci 1988;33:454-459.
88. Teres J, Cecilia A, Bordas JM, Rimola A, Bru C, Rodes J. Esophageal tamponade for bleeding varices. Controlled trial between the Sengstaken-Blakemore tube and the Linton-Nachlas tube. Gastroenterology 1978;75:566-569.
89. Stray N, Jacobsen CD, Rosseland A. Injection sclerotherapy of bleeding oesophageal and gastric varices using a flexible endoscope. Acta Med Scand 1982;211:125-129.
90. Paquet KJ, Feusener H. Endoscopic sclerosis and esophageal balloon tamponade in acute hemorrhage from esophagogastric varices. Hepatology 1985;5:580-583.
91. Sarin SK, Sachdev G, Nanda R, Misra SP, Broor SL. Endoscopic sclerotherapy in the treatment of gastric varices. Br J Surg 1988;75:747-750.
92. Millar AJ, Brown RA, Hill ID, Rode H, Cywes S. The fundal pile: bleeding gastric varices. J Pediatr Surg 1991;26:707-709.
93. Sarin SK, Govil A, Jain AK, Guptan RC, Issar SK, Jain M, Murthy NS. Prospective randomized trial of endoscopic sclerotherapy versus variceal band ligation for esophageal varices: influence on gastropathy, gastric varices and variceal recurrence. J Hepatol 1997;26:826-832.
94. Sarin SK, Jain AK, Jain M, Gupta R. A randomized controlled trial of cyanoacrylate versus alcohol injection in patients with isolated fundic varices. Am J Gastroenterol 2002;97:1010-1015.
95. Soehendra N, Nam VC, Grimm H, Kempeneers I. Endoscopic obliteration of large esophagogastric varices with bucrylate. Endoscopy 1986;18:25-26.
96. Lo GH, Lai KH, Cheng JS, Chen MH, Chiang HT. A prospective, randomized trial of butyl cyanoacrylate injection versus band ligation in the management of bleeding gastric varices. Hepatology 2001;33:1060-1064.
97. Oho K, Iwao T, Sumino M, Toyonaga A, Tanikawa K. Ethanolamine oleate versus butyl cyanoacrylate for bleeding gastric varices: a nonrandomized study. Endoscopy 1995;27:349-354.
98. Akahoshi T, Hashizume M, Shimabukuro R, Tanoue K, Tomikawa M, Okita K, Gotoh N, Konishi K, Tsutsumi N, Sugimachi K. Long-term results of endoscopic Histoacryl injection sclerotherapy for gastric variceal bleeding: a 10-year experience. Surgery 2002;131:S176-S181.
99. Dhiman RK, Chawla Y, Taneja S, Biswas R, Sharma TR, Dilawari JB. Endoscopic sclerotherapy of gastric variceal bleeding with N-butyl-2-cyanoacrylate. J Clin Gastroenterol 2002;35:222-227.
100. Huang YH, Yeh HZ, Chen GH, Chang CS, Wu CY, Poon SK, Lien HC, Yang SS. Endoscopic treatment for bleeding gastric varices by N-butyl-2 cyanoacrylate (Histoacryl) injection: long-term efficacy and safety. Gastrointest Endosc 2000;52:160-167.
101. Yang WL, Tripathi D, Therapondos G, Todd A, Hayes PC. Endoscopic use of human thrombin in bleeding gastric varices. Am J Gastroenterol 2002;97:1381-1385.
102. Williams SGJ, Peters RA, Westaby D. Thrombin-an effective treatment for gastric variceal haemorrhage. Gut 1994;35:1287-1289.
103. Heneghan MA, Byrne A, Harrison PM. An open pilot study of the effects of a human fibrin glue for endoscopic treatment of patients with acute bleeding from gastric varices. Gastrointest Endosc 2002;56:422-426.
104. Miyazaki S, Yoshida T, Harada T, Shigemitsu T, Takeo Y, Okita K. Injection sclerotherapy for gastric varices using N-butyl-2-cyanoacrylate and ethanolamine oleate. Hepatogastroenterology 1998;45:1155-1158.
105. Lee YT, Chan FK, Ng EK, Leung VK, Law KB, Yung MY, Chung SC, Sung JJ. EUS-guided injection of cyanoacrylate for bleeding gastric varices. Gastrointest Endosc 2000;52:168-174.
106. See A, Florent C, Lamy P, Levy VG, Bouvry M. Cerebrovascular accidents after endoscopic obturation of esophageal varices with isobutyl-2-cyanoacrylate in 2 patients. Gastroenterol Clin Biol 1986;10:604-607.
107. Roesch W, Rexroth G. Pulmonary, cerebral and coronary emboli during bucrylate injection of bleeding fundic varices. Endoscopy 1998;30:S89-S90.
108. Thakeb F, Salama Z, Salama H, Abdel Raouf T, Abdel Kader S, Abdel Hamid H. The value of combined use of N-butyl-2-cyano-acrylate and ethanolamine oleate in the management of bleeding esophagogastric varices. Endoscopy 1995;27:358-364.
109. Verger P, Blais J, Gruau M, Haffaf Y. [Retrogastric abscess secondary to gastric varices obturation with cyanoacrylate]. Gastroenterol Clin Biol 1998;22:248-249.
110. Cheng PN, Sheu BS, Chen CY, Chang TT, Lin XZ. Splenic infarction after histoacryl injection for bleeding gastric varices. Gastrointest Endosc 1998;48:426-427.
111. Shim CS, Cho YD, Kim JO, Bong HK, Kim YS, Lee JS, Lee MS, Hwang SG. A case of portal and spienic vein thrombosis after Histoacryl injection therapy in gastric varices. Endoscopy 1996;28:461.
112. Hwang SS, Kim HH, Park SH, Kim SE, Jung JI, Ahn BY, Kim SH, Chung SK, Park YH, Choi KH. N-butyl-2-cyanoacrylate pulmonary embolism after endoscopic injection sclerotherapy for gastric variceal bleeding. J Comput Assist Tomogr 2001;25:16-22.
113. Binmoeller KF. Glue for gastric varices: some sticky issues. Gastrointest Endosc 2000;52:298-301.
114. Binmoeller KF, Soehendra N. New haemostatic techniques: histoacryl injection, banding, endoloop ligation and haemoclipping. Baillieres Clin Gastroenterol 1999;13:85-96.
115. Lee MS, Cho JY, Cheon YK, Ryu CB, Moon JH, Cho YD, Kim JO, Kim YS, Lee JS, Shim CS. Use of detachable snares and elastic bands for endoscopic control of bleeding from large gastric varices. Gastrointest Endosc 2002;56:83-88.
116. Harada T, Yoshida T, Shigemitsu T, Takeo Y, Tada M, Okita K. Therapeutic results of endoscopic variceal ligation for acute bleeding of oesophageal and gastric varices. J Gastroenterol Hepatol 1997;12:331-335.
117. Yoshida T, Hayashi N, Suzumi N, Miyazaki S, Terai S, Itoh T, Nishimura S, Noguchi T, Hino K, Yasunaga M. Endoscopic ligation of gastric varices using a detachable snare. Endoscopy 1994;26:502-505.
118. Cipolletta L, Bianco MA, Rotondano G, Piscopo R, Prisco A, Garofano ML. Emergency endoscopic ligation of actively bleeding gastric varices with a detachable snare. Gastrointest Endosc 1998;47:400-403.
119. Shiha G, El-Sayed SS. Gastric variceal ligation: a new technique. Gastrointest Endosc 1999;49:437-441.
120. Lee MS, Shim CS. Is endoscopic ligation therapy with large detachable snares and elastic bands really safe and effective? Response. Gastrointest Endosc 2003;57:439440.
121. Lo GH, Lai KH. Is endoscopic ligation therapy with large detachable snares and elastic bands really safe and effective? Gastrointest Endosc 2003;57:438-439.
122. Chun HJ, Hyun JH. A new method of endoscopic variceal ligation-injection sclerotherapy (EVLIS) for gastric varices. Korean J Intern Med 1995;10:108-119.
123. Yoshida T, Harada T, Shigemitsu T, Takeo Y, Miyazaki S, Okita K. Endoscopic management of gastric varices using a detachable snare and simultaneous endoscopic sclerotherapy and O-ring ligation. J Gastroenterol Hepatol 1999;14:730-735.
124. Yoshida H, Onda M, Tajiri T, Mamada Y, Taniai N, Mineta S, Yoshioka M, Hirakata A, Yamashita K. New techniques: combined endoscopic injection sclerotherapy and ligation for acute bleeding from gastric varices. Hepatogastroenterology 2002;49:932-934.
125. Papatheodoridis GV, Goulis J, Leandro G. Transjugular intrahepatic portosystemic shunt compared with endoscopic treatment for prevention of variceal rebleeding. Hepatology 1999;30:612-622.
126. Escorsell A, Banares R, Garcia-Pagan JC, Gilabert R, Moitinho E, Piqueras B, Bru C, Echenagusia A, Granados A, Bosch J. TIPS versus drug therapy in preventing variceal rebleeding in advanced cirrhosis: a randomized controlled trial. Hepatology 2002;35:385-392.
127. Stanley AJ, Jalan R, Forrest EH, Redhead DN, Hayes PC. Long-term follow up of transjugular intrahepatic portosystemic stent shunt (TIPSS) for the treatment of portal hypertension: results in 130 patients. Gut 1996;39:479-485.
128. LaBerge JM, Somberg KA, Lake JR, Gordon RL, Kerlan RK, Jr, Ascher NL, Roberts JP, Simor MM, Doherty CA, Hahn J, Bacchetti P, Ring EJ. Two-year outcome following transjugular intrahepatic portosystemic shunt for variceal bleeding: results in 90 patients. Gastroenterology 1995;108:1143-1151.
129. Jalan R, Elton RA, Redhead DN, Finlayson ND, Hayes PC. Analysis of prognostic variables in the prediction of mortality, shunt failure, variceal rebleeding and encephalopathy following the transjugular intrahepatic portosystemic stent-shunt for variceal haemorrhage. J Hepatol 1995;23:123-128.
130. Song HG, Lee HC, Park YH, Jung S, Chung YH, Lee YS, Yoon HK, Sung KB, Suh DJ. [Therapeutic efficacy of transjugular intrahepatic portosystemic shunt on bleeding gastric varices]. Taehan Kan Hakhoe Chi 2002;8:448-457.
131. Chalasani N, Clark WS, Martin LG, Kamean J, Khan MA, Patel NH, Boyer TD. Determinants of mortality in patients with advanced cirrhosis after transjugular intrahepatic portosystemic shunting. Gastroenterology 2000;118:138-144.
132. Malinchoc M, Kamath PS, Gordon FD, Peine CJ, Rank J, ter Borg PC. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology 2000;31:864-871.
133. Barange K, Peron JM, Imani K, Otal P, Payen JL, Rousseau H, Pascal JP, Joffre F, Vinel JP. Transjugular intrahepatic portosystemic shunt in the treatment of refractory bleeding from ruptured gastric varices. Hepatology 1999;30:1139-1143.
134. Chau TN, Patch D, Chan YW, Nagral A, Dick R, Burroughs AK. "Salvage" transjugular intrahepatic portosystemic shunts: gastric fundal compared with esophageal variceal bleeding. Gastroenterology 1998;114:981-987.
135. Rees CJ, Nylander DL, Thompson NP, Rose JD, Record CO, Hudson M. Do gastric and oesophageal varices bleed at different portal pressures and is TIPS an effective treatment? Liver 2000;20:253-256.
136. Stanley AJ, Jalan R, Ireland HM, Redhead DN, Bouchier IA, Hayes PC. A comparison between gastric and oesophageal variceal haemorrhage treated with transjugular intrahepatic portosystemic stent shunt (TIPSS). Aliment Pharmacol Ther 1997;11:171-176.
137. Spahr L, Dufresne M-P, Bui B. Efficacy of TIPS in the prevention of rebleeding from esophageal and fundal varices: a comparative study (abstr). Hepatology 1995;22:296A.
138. Casado M, Bosch J, Garcia-Pagan JC, Bru C, Banares R, Bandi JC, Escorsell A, Rodriguez-Laiz JM, Gilabert R, Feu F, Schorlemer C, Echenagusia A, Rodes J. Clinical events after transjugular intrahepatic portosystemic shunt: correlation with hemodynamic findings. Gastroenterology 1998;114:1296-1303.
139. Lind CD, Malisch TW, Chong WK, Richards WO, Pinson CW, Meranze SG, Mazer M. Incidence of shunt occlusion or stenosis following transjugular intrahepatic portosystemic shunt placement. Gastroenterology 1994;106:1277-1283.
140. Pomier-Layrargues G, Villeneuve J-P, Deschenes M, Bui B, Perrault P, Fenyves D, Willems B, Marleau D, Bilodeau M, Lafortune M, Dufresne M-P. Transjugular intrahepatic portosystemic shunt (TIPS) versus endoscopic variceal ligation in the prevention of variceal rebleeding in patients with cirrhosis: a randomised trial. Gut 2001;48:390-396.
141. Schlegel PM, Tombach B, Reimer P, Vestring T, Menzel J, Moller HE, Heindel W. [The value of magnetic resonance imaging (MRI) for the follow-up of patients with transjugular intrahepatic portosystemic shunts (TIPS)]. Rofo Fortschr Geb Rontgenstr Neuen Bildgeb Verfahr 2002;174:224-230.
142. Hansmann HJ, Noldge G, Leutloff U, Radeleff B, Sauer P, Richter GM. [Radiologic after-care of transjugular intrahepatic stent shunt (TIPSS)]. Radiologe 2001;41:884-890.
143. Grace ND. TIPS: the long and the short of it. Gastroenterology 1997;112:1040-1043.
144. Ono N, Toyonaga A, Nishimura H, Hayabuchi N, Tanikawa K. Evaluation of magnetic resonance angiography on portosystemic collaterals in cirrhotic patients. Am J Gastroenterol 1997;92:1515-1519.
145. Chikamori F, Kuniyoshi N, Shibuya S, Takase Y. Urgent transjugular retrograde obliteration for prophylaxis of rebleeding from gastric varices in patients with a spontaneous portosplenorenal shunt. Dig Surg 2000;17:23-28.
146. Chikamori F, Kuniyoshi N, Shibuya S, Takase Y. Eight years of experience with transjugular retrograde obliteration for gastric varices with gastrorenal shunts. Surgery 2001;129:414-420.
147. Fukuda T, Hirota S, Sugimura K. Long-term results of balloon-occluded retrograde transvenous obliteration for the treatment of gastric varices and hepatic encephalopathy. J Vasc Interv Radiol 2001;12:327-336.
148. Hirota S, Matsumoto S, Tomita M, Sako M, Kono M. Retrograde transvenous obliteration of gastric varices. Radiology 1999;211:349-356.
149. Kato T, Uematsu T, Nishigaki Y, Sugihara J, Tomita E, Moriwaki H. Therapeutic effect of balloon-occluded retrograde transvenous obliteration on portal-systemic encephalopathy in patients with liver cirrhosis. Intern Med 2001;40:688-691.
150. Oho K, Iwao T, Sakai T, Tayama C, Sato M, Nakano R, Toyonaga A, Tanikawa K. Randomized prospective trial for bleeding fundal varices: endoscopic sclerotherapy versus transvenous obliteration. Gastroenterology 1997;112:A1351.
151. Matsumoto A, Hamamoto N, Kayazawa M. Balloon endoscopic sclerotherapy, a novel treatment for high-risk gastric fundal varices: a pilot study. Gastroenterology 1999;117:515-516.
152. Kiyosue H, Matsumoto S, Onishi R, Okahara M, Hori Y, Yamada Y, Dono S, Mori H. [Balloon-occluded retrograde transvenous obliteration (B-RTO) for gastric varices: therapeutic results and problems]. Nippon Igaku Hoshasen Gakkai Zasshi 1999;59:12-19.
153. Kanagawa H, Mima S, Kouyama H, Gotoh K, Uchida T, Okuda K. Treatment of gastric fundal varices by balloon-occluded retrograde transvenous obliteration. J Gastroenterol Hepatol 1996;11:51-58.
154. Ohishi W, Kitamoto M, Takaishi H, Takahashi S, Tsuji K, Masanaga T, Aikata H, Nakanishi T, Orime S, Okanobu H, Yamanaka H, Ono E, Kajiyama G. [A case of gastric varices treated with B-RTO followed by 3D-CT angiography]. Nippon Shokakibyo Gakkai Zasshi 1998;95:1018-1021.
155. Kin H, Kubota Y, Tsuji K, Takeuchi Y, Takaoka M, Ogura M, Yamamoto S, Yanagitani K, Yanagitani S, Inoue K, Kurokawa H, Tanaka Y. MR imaging in the evaluation of the therapeutic effect of B-RTO for gastric varices. Hepatogastroenterology 1998;45:677-683.
156. Hamamoto N, Matsumoto A, Nomura T, Kayazawa M, Hirata I, Morikawa H, Katsu K. Treatment of gastric fundal varices by balloon endoscopic sclerotherapy. Gastrointest Endosc 1999;49:115-118.
157. Shiba M, Higuchi K, Nakamura K, Itani A, Kuga T, Okazaki H, Fujiwara Y, Arakawa T. Efficacy and safety of balloon-occluded endoscopic injection for sclerotherapy as a prophylactic treatment for high-risk gastric varices: a prospective, randomized, comparative clinical trial. Gastrointest Endosc 2002;56:522-528.
158. Shiba M, Higuchi K, Nakamura K, Kuga T, Hamasaki N, Ando K, Fujiwara Y, Saeki Y, Arakawa T, Yamada R, Kuroki T. A case of huge gastric varices successfully treated with endoscopic injection sclerotherapy with occlusion of both supplying and draining veins with balloons. Gastrointest Endosc 2000;52:104-107.
159. Jackson FC, Perrin EB, Smith AG, Dagradi AE, Nadal HM. A clinical investigation of the portacaval shunt II. Survival analysis of the prophylactic operation. Am J Surg 1968;115:22-42.
160. Conn HO, Lindenmuth WW, May CJ, Ramsby GR. Prophylactic portacaval anastomosis in cirrhotic patients with esophageal varices. N Engl J Med 1965;272:1255-1263.
161. Thomas PG, D'Cruz AJ. Distal splenorenal shunting for bleeding gastric varices. Br J Surg 1994;81:241-244.